Home / LINCOLN.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does LINCOLN.NS make money? Does LINCOLN.NS have pricing power? What's the Earnings Whisper? Will LINCOLN.NS profit more as the business scales? What is LINCOLN.NS's management track record? Is LINCOLN.NS's current price justified?

Lincoln Pharmaceuticals Limited

₹545.6 +$65.80 (+13.71%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹555

Day Range

₹540.7₹559.1

Year Range

₹440₹770

Market Cap

10.93B

AVG Volume

47K

Trailing/Forward PE

11.33/20.31

PEG ratio

0.63

Dividend Yield

0.33%

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

LINCOLN.NS Revenue (INR) by year
Period	Revenue (INR)
2026	6.71B
2025	6.23B
2024	5.81B
2023	5.1B
2022	4.68B
2021	4.24B
2020	3.86B
2019	3.66B
2018	3.72B
2017	3.59B

Net Income (INR) · A

LINCOLN.NS Net Income (INR) by year
Period	Net Income (INR)
2026	878.94M
2025	823.46M
2024	933.05M
2023	728.98M
2022	693.48M
2021	622.24M
2020	514.39M
2019	487.1M
2018	346.23M
2017	273.3M

Operating Income (INR) · A

LINCOLN.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	831.84M
2025	885.94M
2024	832.22M
2023	806.75M
2022	883.95M
2021	818.11M
2020	608.7M
2019	614.34M
2018	478.1M
2017	438.38M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Lincoln Pharmaceuticals Limited

Video analysis: LINCOLN.NS

News: LINCOLN.NS

Similar companies